Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators
Anticancer Research · 2023
DOI: 10.21873/anticanres.16151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Kenichiro Araki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan;…. Hauptthemen laut MEDLINE: Liver Neoplasms, Embolization, Therapeutic.
Abstract (Originalsprache)
BACKGROUND/AIM: The relationship between body composition including skeletal muscle and liver hypertrophy initiated by portal vein embolization (PVE) for major hepatectomy has not been clarified. This study aimed to investigate the effects of skeletal muscle, body adipose, and nutritional indicators on liver hypertrophy. PATIENTS AND METHODS: Fifty-nine patients who underwent PVE scheduled for major right-sided hepatectomy were included. The skeletal muscle area of L3 as skeletal muscle index was calculated. The relationship between skeletal muscle loss and clinical variables was assessed. We also evaluated the relationship between >30% liver growth or >12% liver growth/week after PVE. RESULTS: Skeletal muscle loss was observed in 39 patients (66.1%) and associated with zinc deficiency, visceral adipose index, liver growth rate, and liver growth rate/week. Multivariate analysis indicated that future liver volume and skeletal muscle index were associated with >30% liver growth, and functional future liver volume and skeletal muscle index were associated with >12% liver growth/week. CONCLUSION: Loss of skeletal muscle, and a small future remnant liver volume, attenuates liver hypertrophy initiated by PVE. Strength building and nutritional supplementation may have positive effects on liver hypertrophy after PVE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan; karaki@gunma-u.ac.jp.
- Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
- Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Gunma, Japan.
- Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma, Japan.
Zitieren
APA
Araki, K., Harimoto, N., Shibuya, K., Watanabe, A., Tsukagoshi, M., Ishii, N., Hagiwara, K., Muranushi, R., Hoshino, K., Seki, T., & Shirabe, K. (2023). Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators. Anticancer Research. https://doi.org/10.21873/anticanres.16151
Vancouver
Araki K, Harimoto N, Shibuya K, Watanabe A, Tsukagoshi M, Ishii N, et al. Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators. Anticancer Research. 2023. doi:10.21873/anticanres.16151
BibTeX
@article{Araki2023,
author = {Araki, Kenichiro and Harimoto, Norifumi and Shibuya, Kei and Watanabe, Akira and Tsukagoshi, Mariko and Ishii, Norihiro and Hagiwara, Kei and Muranushi, Ryo and Hoshino, Kouki and Seki, Takaomi and Shirabe, Ken},
title = {Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16151}
}
EUVIMED